Understanding Epileptogenesis from Molecules to Network Alteration
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Epilepsy is characterized by recurrent seizures. Following an initial insult, a latent period precedes the onset of spontaneous seizures, a process referred to as epileptogenesis. This period plays a critical role in halting the progression toward epilepsy before the onset of abnormal molecular and network alterations. In this study, the fundamental concepts of epileptogenesis as well as the associated molecular and cellular targets are reviewed.
References
1.
Devinsky O, Vezzani A, Najjar S, de Lanerolle N, Rogawski M
. Glia and epilepsy: excitability and inflammation. Trends Neurosci. 2013; 36(3):174-84.
DOI: 10.1016/j.tins.2012.11.008.
View
2.
Simonato M, Agoston D, Brooks-Kayal A, Dulla C, Fureman B, Henshall D
. Identification of clinically relevant biomarkers of epileptogenesis - a strategic roadmap. Nat Rev Neurol. 2021; 17(4):231-242.
DOI: 10.1038/s41582-021-00461-4.
View
3.
Johnson E, Krauss G, Lee A, Schneider A, Dearborn J, Kucharska-Newton A
. Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study. JAMA Neurol. 2018; 75(11):1375-1382.
PMC: 6248112.
DOI: 10.1001/jamaneurol.2018.1935.
View
4.
Vezzani A, Pascente R, Ravizza T
. Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions. Neurochem Res. 2017; 42(7):2089-2098.
DOI: 10.1007/s11064-017-2271-3.
View
5.
Pitkanen A, Engel Jr J
. Past and present definitions of epileptogenesis and its biomarkers. Neurotherapeutics. 2014; 11(2):231-41.
PMC: 3996117.
DOI: 10.1007/s13311-014-0257-2.
View